Evaluation of the clinical value of contrast enhanced ultrasound in the diagnostic and follow-up of renal cell cancer

• Conditions: renal cancer; 10038430; renal cell carinoma; 10038364

• Registration Number: NL-OMON31004
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Patients with renal cell carcinoma who wil be operated or patients with complicated cysts who will be followed-up

Exclusion Criteria

severe cardial co-morbidity, New York Heart Association class IV cardiac failure.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Our primary objective is to establish the diagnostic accuracy of CE-US in renal<br /><br>masses suspicious for RCC.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Our secondary objective is to establish the pattern of vascularisation in the<br /><br>different sub-types of RCC. </p><br>